| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 09/17/1998 | CA2283461A1 Adenoviral vectors with modified tropism |
| 09/17/1998 | CA2283195A1 Secreted proteins and polynucleotides encoding them |
| 09/17/1998 | CA2283193A1 Secreted proteins and polynucleotides encoding them |
| 09/17/1998 | CA2283173A1 Hydroxy and ether-containing oxyalkylene esters and uses thereof |
| 09/17/1998 | CA2283162A1 Oxyalkylene phosphate compounds and uses thereof |
| 09/17/1998 | CA2282710A1 Lta4 hydrolase inhibitors |
| 09/17/1998 | CA2282349A1 Lta4 hydrolase inhibitors |
| 09/16/1998 | EP0864323A1 Pharmaceutical preparation for oral application containing a histamine-immunoglobulin complex |
| 09/16/1998 | EP0864321A1 Composition containing collagen, method of preparation and uses |
| 09/16/1998 | EP0864320A1 Stable oil-in-water emulsion, its process of manufacturing and its use in the cosmetical and dermatological fields |
| 09/16/1998 | EP0863991A1 Antigenic preparations |
| 09/16/1998 | EP0863911A1 ANTISENSE OLIGONUCLEOTIDE MODULATION OF raf GENE EXPRESSION |
| 09/16/1998 | EP0863903A1 Synthetic metal-substituted bacteriochlorophyll derivatives and use thereof |
| 09/16/1998 | EP0863744A2 Lipoic acid in topical compositions |
| 09/16/1998 | EP0863741A2 Reduction of hair growth |
| 09/16/1998 | EP0863740A1 Reduction of hair growth |
| 09/16/1998 | EP0733047B1 Substituted oxazolidines with stimulating effect of beta-adrenergig receptor |
| 09/16/1998 | CN1193325A Cell adhension inhibitors |
| 09/16/1998 | CN1193313A Propynyl or dienyl diaromatic compounds |
| 09/16/1998 | CN1192929A Oral medicinal preparation |
| 09/15/1998 | US5808037 Oligomers which inhibit expression of collagen genes |
| 09/15/1998 | US5807900 Method for identifying compounds having increased activity for the repair of skin photodamage |
| 09/15/1998 | US5807890 Antiodor, antimicrobial and preservative compositions and methods of using same |
| 09/15/1998 | US5807884 Treatment for atherosclerosis and other cardiovascular and inflammatory diseases |
| 09/15/1998 | US5807849 Therapeutic methods and delivery systems utilizing sex steroid precursors |
| 09/15/1998 | US5807824 C5A receptor antagonists having substantially no agonist activity |
| 09/15/1998 | US5807820 Cyclosporin compositions for topical application |
| 09/15/1998 | US5807600 Using salts of a-hydroxyacids |
| 09/15/1998 | US5807555 Skin treatments with Smelophyllum capense extracts |
| 09/13/1998 | CA2231743A1 Collagen-based composition and process for preparing it |
| 09/11/1998 | WO1998039444A1 Protein kinase c inhibitor-like protein (ipkc-2) |
| 09/11/1998 | WO1998039332A1 2-aryl-naphthyridin-4-ones as antitumor agents |
| 09/11/1998 | WO1998039329A1 Amidoaromatic ring sulfonamide hydroxamic acid compounds |
| 09/11/1998 | WO1998039303A1 Small molecules useful in the treatment of inflammatory disease |
| 09/11/1998 | WO1998039292A1 20-epi-22(r)-lower alkyl-substituted vitamin d derivatives and calcium metabolism improving agents containing the same as the active ingredient |
| 09/11/1998 | WO1998039284A1 Aryl- and heteroarylcyclohexenyl substituted alkenes having retinoid agonist, antagonist or inverse agonist type biological activity |
| 09/11/1998 | WO1998039034A2 Use of preparations containing anti-cd44 antibodies in the treatment of certain tumours and the suppression of immune reactions |
| 09/11/1998 | WO1998039020A1 Methods for treatment of scar tissue |
| 09/11/1998 | WO1998038966A1 Sunscreen compositions containing damaged rna fragments |
| 09/11/1998 | WO1998038859A1 Sulfonyl divalent aryl or heteroaryl hydroxamic acid compounds |
| 09/11/1998 | WO1998038854A1 Pharmaceutical composition and methods for using it |
| 09/11/1998 | WO1998030193A3 Bar composition comprising low viscosity oils pre-thickened by non-antifoaming hydrophobic polymers |
| 09/11/1998 | WO1998023243A3 Pharmaceutical, cosmetic composition with base of microbial culture mixed with an essential oil and an acid |
| 09/11/1998 | CA2285405A1 Amidoaromatic ring sulfonamide hydroxamic acid compounds |
| 09/11/1998 | CA2283415A1 Aryl- and heteroarylcyclohexenyl substituted alkenes having retinoid agonist, antagonist or inverse agonist type biological activity |
| 09/11/1998 | CA2283275A1 Sulfonyl divalent aryl or heteroaryl hydroxamic acid compounds |
| 09/11/1998 | CA2283272A1 Aromatic sulfonyl alpha-cycloamino hydroxamic acid compounds |
| 09/11/1998 | CA2283145A1 Aromatic sulfonyl alpha-hydroxy hydroxamic acid compounds |
| 09/11/1998 | CA2282709A1 Protein kinase c inhibitor-like protein (ipkc-2) |
| 09/11/1998 | CA2282399A1 Thioaryl sulfonamide hydroxamic acid compounds |
| 09/11/1998 | CA2282318A1 N-hydroxy 4-sulfonyl butanamide compounds |
| 09/11/1998 | CA2281934A1 Use of preparations containing anti-cd44 antibodies for the treatment of certain tumours and for the supression of immune reactions |
| 09/11/1998 | CA2278547A1 Small molecules useful in the treatment of inflammatory disease |
| 09/09/1998 | EP0863208A2 Histidine Kinase polypeptides, polynucleotides encluding the same and use thereof |
| 09/09/1998 | EP0863207A1 RNA dependent amidotransferase A from Staphylococcus Aureus |
| 09/09/1998 | EP0862910A2 Use of retinoids as skin pigmentation inducing agent |
| 09/09/1998 | EP0862630A2 HUMANIZED ANTIBODIES TO HUMAN gp39, COMPOSITIONS CONTAINING AND THERAPEUTIC USE THEREOF |
| 09/09/1998 | EP0862567A1 5-azabicyclo(3.1.0)hexylalkyl-2-piperidones and -glutarimides as neurokinin receptor antagonists |
| 09/09/1998 | EP0862564A1 Photoactivatable compounds for the prevention of intimal hyperplasia and other diseases |
| 09/09/1998 | EP0862559A1 Novel fluorinated or hydroxylated phenylimidazolidines having anti-androgenic activity, method for preparing same, resulting intermediates, and pharmaceutical compositions |
| 09/09/1998 | EP0862554A1 Aromatic carboxylic acid esters, the production of same and use of same as medicaments |
| 09/09/1998 | EP0862547A1 Products extracted from a plant of the genus commiphora, particularly the commiphora mukul plant, extracts containing same and applications thereof, for example in cosmetics |
| 09/09/1998 | EP0862440A1 Therapeutic use of hemoglobin in promoting wound healing |
| 09/09/1998 | EP0691966B1 Quinolines as type iv phosphodiesterase inhibitors |
| 09/09/1998 | EP0651641B1 Novel bioactive compositions, preparation and use thereof |
| 09/09/1998 | CN1192779A Monkey monoclonal antibodies specific to human b. 7.1 and/or B7.2 primatized forms, pharmaceutical compositions |
| 09/09/1998 | CN1192368A External use pharmaceutical compositions for treating vitiligo and its prepn. method |
| 09/09/1998 | CN1192361A Traditional Chinese medicinal prepn. for treating various kinds of pustule, lump and ulceration wound |
| 09/09/1998 | CN1192359A Paste for treating face skin ulcer and method for preparing same |
| 09/09/1998 | CN1192358A 聚维酮碘膜剂 Povidone iodine agent |
| 09/09/1998 | CN1039672C Quick-drying gel-type disinfectant for hands and fingers |
| 09/08/1998 | US5804572 Compositions for regulating skin wrinkles and/or skin atrophy |
| 09/08/1998 | US5804551 Stroma-free modified hemoglobin; improving recovery |
| 09/08/1998 | US5804540 Moisturizing liquid skin cleansers |
| 09/08/1998 | US5804176 Compositions comprising leukocyte-derived growth factors and methods of administering same to facilitate wound healing |
| 09/03/1998 | WO1998038320A1 Component of bromelain |
| 09/03/1998 | WO1998038167A1 Heteroaryl-hexanoic acid amide derivatives, their preparation and their use as selective inhibitors of mip-1-alpha binding to its ccr1 receptor |
| 09/03/1998 | WO1998038165A1 S-2'-(2-(1-methyl-2-piperidyl) ethyl) cinnamanilide as a 5-ht2 receptor antagonist |
| 09/03/1998 | WO1998038163A1 N-hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
| 09/03/1998 | WO1998037901A1 Self-regulated apoptosis of inflammatory cells by gene therapy |
| 09/03/1998 | WO1998037896A1 Treatment of eosinophil-associated pathologies, such as bronchial asthma, with synergistic combinations of glucocorticoids and a local anesthetics |
| 09/03/1998 | WO1998037877A1 N-hydroxy-2-(alkyl, aryl or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
| 09/03/1998 | WO1998037866A1 Mild antimicrobial liquid cleansing formulations comprising hydroxy acid buffering compound or compounds as potentiator of antimicrobial effectiveness |
| 09/03/1998 | CA2282656A1 N-hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
| 09/03/1998 | CA2282655A1 N-hydroxy-2-(alkyl, aryl or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
| 09/03/1998 | CA2282639A1 Treatment of eosinophil-associated pathologies, such as bronchial asthma, with synergistic combinations of glucocorticoids and a local anesthetics |
| 09/03/1998 | CA2281567A1 Self-regulated apoptosis of inflammatory cells by gene therapy |
| 09/02/1998 | EP0861266A1 Peptide conjugates derived from thymic hormones, their use as medicament and compositions containing them |
| 09/02/1998 | EP0861260A1 Improved method and agents for inhibiting protein aging |
| 09/02/1998 | EP0861238A1 Hexahydro-5-imino-1,4-heteroazepine derivatives as inhibitors of nitric oxide synthases |
| 09/02/1998 | EP0861074A1 Non-ionic surfactant vesicles as therapeutic agent |
| 09/02/1998 | EP0861032A1 Aquatic animal treatment method and composition containing cajeput oil |
| 09/02/1998 | CN1192147A Imidazole compounds |
| 09/02/1998 | CN1192134A Topical vehicles containing solubilized and stabilized azelaic acid |
| 09/02/1998 | CN1191748A Spray preparation for burns and scald and its preparation process |
| 09/02/1998 | CN1191747A Congelation treating suspension |
| 09/01/1998 | US5801253 Retinoic acid X-receptor ligands |
| 09/01/1998 | US5801163 Use of salicylic acid for regulating skin wrinkles and/or skin atrophy |
| 09/01/1998 | US5801156 Macular degeneration |
| 09/01/1998 | US5801044 Nucleic acid encoding an antibody that inhibits cell adhesion protein-carbohydrate interactions |